Examkin

Question

Difficulty: HardCardiovascular System

A 28-year-old woman presents to the emergency department complaining of a sudden onset of rapid heart palpitations and mild chest fullness that began 30 minutes ago while she was watching television. She denies any chest pain, lightheadedness, or loss of consciousness. Her vital signs are temperature 37.0°C (98.6°F), blood pressure 118/76 mmHg, heart rate 175/min, and respiratory rate 16/min. Physical examination reveals a rapid, regular pulse and clear lungs. A 12-lead electrocardiogram (ECG) demonstrates a regular, narrow-complex tachycardia at a rate of 175/min with no discernible P waves.

Arrange the following therapeutic interventions in the most appropriate chronological sequence for the acute and definitive management of this condition, assuming each preceding step is ineffective.

  1. 1Instruct the patient to perform a modified Valsalva maneuver
  2. 2Administer a rapid intravenous bolus of adenosine
  3. 3Administer an intravenous non-dihydropyridine calcium channel blocker
  4. 4Perform synchronized direct current cardioversion
  5. 5Schedule an outpatient electrophysiology study and radiofrequency catheter ablation

Answer

The correct sequence for managing stable supraventricular tachycardia is: modified Valsalva maneuver, rapid intravenous adenosine, intravenous non-dihydropyridine calcium channel blocker, synchronized direct current cardioversion, and finally, outpatient electrophysiology study with radiofrequency catheter ablation.
The patient's presentation of a regular, narrow-complex tachycardia at 175/min with no visible P waves in a young, healthy individual is classic for paroxysmal supraventricular tachycardia (PSVT), most commonly atrioventricular nodal reentrant tachycardia (AVNRT). The management algorithm strictly depends on hemodynamic stability. Because she is completely stable (normal blood pressure, mentation, and respiration), management should follow a step-wise escalating approach. The initial step is always a vagal maneuver (e.g., Valsalva or carotid sinus massage) to increase vagal tone and transiently slow AV nodal conduction, which can break the reentrant circuit. If this fails, the first-line medication is a rapid intravenous push of adenosine. Adenosine acts on A1 receptors to cause temporary AV nodal block; its extremely short half-life (<10 seconds) makes it safe and highly effective. If adenosine does not restore sinus rhythm, longer-acting AV nodal blocking agents, such as non-dihydropyridine calcium channel blockers (diltiazem, verapamil) or beta-blockers, are administered next. Synchronized direct current cardioversion is indicated in a stable patient only if these pharmacological interventions fail, or as the very first step if the patient suddenly becomes hemodynamically unstable. Finally, following the resolution of the acute episode, the patient should be referred for an outpatient electrophysiology study and radiofrequency catheter ablation. Ablation of the slow AV nodal pathway provides a definitive, long-term cure for AVNRT and is recommended to prevent recurrent symptomatic episodes.

Step-by-Step Solution

1
Assess the patient's hemodynamic stability and electrocardiographic findings.
The patient is hemodynamically stable with a regular, narrow-complex tachycardia without P waves, consistent with paroxysmal supraventricular tachycardia (PSVT).
Stability determines whether to use a step-wise pharmacological approach or proceed directly to emergent electrical cardioversion.
2
Determine the first-line non-pharmacological intervention.
A modified Valsalva maneuver is selected.
Vagal maneuvers increase parasympathetic tone to the AV node and can safely terminate the reentrant circuit without the need for medications.
3
Select the initial pharmacological therapy if the vagal maneuver fails.
Rapid intravenous adenosine is chosen.
Adenosine transiently blocks AV nodal conduction and is highly effective for terminating AV node-dependent arrhythmias; its ultra-short half-life minimizes prolonged side effects.
4
Identify the second-line pharmacological therapy if adenosine is ineffective.
An intravenous non-dihydropyridine calcium channel blocker (e.g., diltiazem) or beta-blocker is selected.
Longer-acting AV nodal blocking agents provide sustained rate control and can convert refractory stable SVT.
5
Determine the next acute step if all pharmacological options fail.
Synchronized direct current cardioversion is identified.
Electrical cardioversion is reserved for stable patients whose arrhythmia is refractory to maximal medical therapy, or immediately if instability develops.
6
Establish the definitive long-term management strategy.
Referral for an electrophysiology study and radiofrequency catheter ablation.
Ablation of the slow AV nodal pathway provides a definitive cure for typical AV nodal reentrant tachycardia, preventing future episodes.

Key Concept

The management of hemodynamically stable paroxysmal supraventricular tachycardia (PSVT) follows a strict step-wise escalation: vagal maneuvers, rapid intravenous adenosine, intravenous non-dihydropyridine calcium channel blockers or beta-blockers, synchronized electrical cardioversion, and ultimately, definitive catheter ablation.
Estimated Time:1m 30s
Rate this question

Topics

Cardiovascular System

More questions from this topic